Business Context and Reporting Period
This Form 6-K filing is submitted by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in the metadata request) for the month of August 2021. The filing serves to incorporate by reference a press release dated August 30, 2021 (Exhibit 99.1), which is the primary source of material information in this report.
Financial Metrics
The filing text provided does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts solely as a conduit for the attached press release.
Material Changes
The filing does not detail specific material changes to financial performance or operations in the text provided. It references a press release for details on material events but does not summarize the content of that release beyond noting its existence.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It notes that quotes from Dr. Raj Parekh and Mr. Onno van de Stolpe are contained in the attached Exhibit 99.1 but does not reproduce them in the body of the Form 6-K.
Key Facts for Investor Verification
- Entity Discrepancy: The metadata lists "Lakefront Biotherapeutics NV," but the filing is explicitly for "Galapagos NV." Investors must verify the correct entity.
- Source of Information: All material information regarding the August 30, 2021 event is located in Exhibit 99.1 (the press release), which is not included in the provided text.
- No Financial Data: This specific filing contains no financial statements or metrics; it is a procedural filing to distribute a press release.
- Registration Statements: The information is incorporated by reference into multiple Forms F-3 and S-8 registration statements.